Profound Medical Corp (PRN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 936 | 1,146 | 1,604 | 1,879 | 1,538 |
| Accounts receivable | 186 | -956 | -1,424 | 1,996 | -3,849 |
| Accounts payable and accrued liabilities | 815 | 1,356 | -566 | -356 | 102 |
| Other Working Capital | 591 | 374 | -5,629 | -877 | -4,635 |
| Other Operating Activity | -25,981 | -24,217 | -19,785 | -25,002 | -13,730 |
| Operating Cash Flow | $-23,453 | $-22,297 | $-25,800 | $-22,360 | $-20,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | -32 | N/A |
| Purchase Sale Intangibles | N/A | N/A | 0 | -561 | -350 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-593 | $-350 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 7,273 | N/A | N/A |
| Debt Repayment | -2,560 | -1,204 | -356 | -386 | -9,606 |
| Common Stock Issued | 62,106 | N/A | N/A | 0 | 85,523 |
| Other Financing Activity | -4,850 | 2,668 | 114 | 6,334 | 11,516 |
| Financing Cash Flow | $54,696 | $1,464 | $7,031 | $5,948 | $87,433 |
| Exchange Rate Effect | -2,544 | 529 | -1,866 | 244 | 2,604 |
| Beginning Cash Position | 26,213 | 46,517 | 67,152 | 83,913 | 14,800 |
| End Cash Position | 54,912 | 26,213 | 46,517 | 67,152 | 83,913 |
| Net Cash Flow | $31,243 | $-20,833 | $-18,769 | $-17,005 | $66,509 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,453 | -22,297 | -25,800 | -22,360 | -20,574 |
| Capital Expenditure | N/A | N/A | N/A | -593 | -350 |
| Free Cash Flow | -23,453 | -22,297 | -25,800 | -22,953 | -20,924 |